Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 35 Medical Device VC (Venture Capital) Funds in Finland in May 2025

Last updated: May 2025 A list of 35 VC (Venture Capital) funds that invest in Medical device startups based in Finland. We rank investors based on the number of investments they made in Medical device companies from Finland. We update this investor list every month.

Top 35 Medical Device VC (Venture Capital) Funds in Finland in May 2025

Investor	Medical Device Finland investments
Lifeline Ventures	6
Innovestor	4
Butterfly Ventures	4
Voima Ventures	4
Finnvera Venture Capital	3
Inventure	3
Icebreaker.vc	3
Tesi	3
Business Finland	3
Cor Group	2
HealthCap	2
EQT Life Sciences	2
Capricorn Partners	2
VTT Ventures	2
Almaral	2
Redstone.VC	2
Springvest	2
Nostetta Ventures	2
XR Invest	1
Metsola Ventures	1
Nidoco	1
High-Tech Gruenderfonds	1
Noaber	1
Lundbeckfonden Ventures	1
Sitra	1
University of Helsinki	1
Gerresheimer Glas	1
Restone Capital	1
Inveni Capital	1
Italian Angels for Growth	1
MVM Life Science Partners	1
Flashpoint	1
Visionplus	1
Nina Capital	1
Amor & Labor Oy	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

Bought — A fully automated secondhand marketplace unleashing the 95% of hidden secondhand supply with AI.
Soldera — Soldera enables renewable energy producers to earn additional income through an automatic guarantee of the origin trading system.
TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Investment focus

Software, Health Care, Manufacturing
Seed, Funding Round, Series A
Finland, Denmark, Sweden

Portfolio highlights

Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
Bahn Express — Fast and Effortless Car Transport
Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Pre-Seed
Finland, Sweden, Norway

Portfolio highlights

Zenniz — Zenniz is an ITF approved game tracking solution that provides real-time info, such as automated line calling, stroke and serve speeds, shot charts, match statistics and more. Players and coaches at all levels can use Zenniz on and off the court to help improve their game. For tennis clubs, Zenniz is an easy and cost-effective way to upgrade to thenext level. Due to a new, innovative sensor technology, they’ve been able to keep the cost to a minimum, making Zenniz accessible for all clubs, coaches and players.
Hypertype — Smartest email experience ever made.
Happy Plant Protein — Changing the way plant proteins are made

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Investment focus

Biotechnology, Health Care, Medical Device
Seed, Pre-Seed, Funding Round
Finland, Sweden, Norway

Portfolio highlights

Skyfora — Skyfora combines scientific understanding of tropical storms with computer vision, machine learning and IoT technologies.
StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
Liquid Sun — Liquid Sun Ltd. We fight against climate change by recoding CO2 emissions to fossil-free fuels and chemicals. Our technology is based low temperature electrolyzers.

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Investment focus

Health Care, Software, Information Technology
Seed, Funding Round, Series A
Finland, United States, Switzerland

Portfolio highlights

AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Series B
Finland, Sweden, Denmark

Portfolio highlights

Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Biomatter — Biomatter Designs is pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Finland, Sweden, Estonia

Portfolio highlights

Grid Raven — Maximize the safety and capacity of your grid with accurate ratings based on our hyper-local weather model that accounts with every tree, building and hill.
Clock & Cloud — AI-driven platform delivering actionable geopolitical intelligence for proactive decision-making and enhanced business security
Fleetbrains — At Fleetbrains, we transform fleet sales and stock management with cutting-edge AI, enabling dealerships and manufacturers to optimize stock, maximize margins, and accelerate vehicle turnover.Our intelligent platform leverages Big Data, Machine Learning, and Large Language Models to predict demand, streamline inventory management, and enhancebusiness decision-making. By redefining traditional sales and forecasting models, we help automotive businesses minimize stock leftovers, improve purchasing strategies, and drive higher profitability.Join us in shaping the future of automotive sales with AI-powered intelligence.

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Investment focus

Software, Manufacturing, Health Care
Funding Round, Series A, Series B
Finland, United States, Argentina

Portfolio highlights

Seaber — Seaber is a cloud-based real-time planning, optimisation and communication solution for bulk cargo & vessels. Our solution improves the efficiency of bulk & break bulk charterers, shipowners & brokers through schedule planning and stakeholder communications over the lifecycle of a voyage.
TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.
TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Investment focus

Software, SaaS, Biotechnology
Seed, Grant, Funding Round
Finland, United States, United Kingdom

Portfolio highlights

TheStorage — Flexible industrial heat electrification and scalable energy storage. TheStorage offers cost efficient, sustainable grid scale energy storage that can discharge heat, steam or CHP.
SparkReceipt — AI-powered Receipt Scanner and Expense Tracker for Individuals and Small Businesses. Create your free account now!
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Cor Group management consulting firm serving Psychological, Educational, and Behavioral Services.

Investment focus

Health Care, Medical, Biotechnology
Seed, Pre-Seed, Series A
Finland

Portfolio highlights

Gosta Labs — Focus on care
Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Nightingale Health — The most advanced health check for the health industry.

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Investment focus

Biotechnology, Health Care, Medical
Series B, Series A, Funding Round
United States, Sweden, France

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, The Netherlands, Switzerland

Portfolio highlights

Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
Avidicure — Avidicure is developing dual agonistic avidity-engineered multifunctional antibodies, AVC-Boosters, as monotherapy for treatment of cancer
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Investment focus

Biotechnology, Health Care, Software
Funding Round, Series B, Series A
Belgium, United States, The Netherlands

Portfolio highlights

InsectSense — MIMICKING HOW INSECTS SENSE | Biomimetic technology based on the sensing mechanism of insects. A deeptech platform that applies synthetic biology, microfluidics and is powered by machine learning.
Minze Health — Minze Health is a health tech start-up that builds creative digital health solutions for urology, pelvic health, and (in)continence care.
Econic Technologies — At Econic, we are pioneering the transformation of CO2 into high-performance materials that shape a better future for all.

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Investment focus

Biotechnology, Manufacturing, 3D Technology
Seed, Funding Round, Series A
Finland

Portfolio highlights

Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.

Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.

Investment focus

Software, Education, E-Learning
Seed, Funding Round
Finland

Portfolio highlights

Seppo — Seppo is an online programme for creating educational games. It can be used on all levels from pre-school to university.
Marginum — Pioneering the next-generation quantitative surgical techniques.
Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

The Redstone team is an international and diverse group of serial entrepreneurs, investors, investment professionals, tech analysts and data scientists.

Investment focus

Software, Information Technology, Health Care
Seed, Series A, Funding Round
Germany, Finland, France

Portfolio highlights

Aslan — Aslan a platform or solution designed to enhance employee benefits by offering more customizable and flexible compensation options.
Ochy — Ochy is an app that uses AI to analyse running form and gait to identify weak points and provide recommendations on what to do to improve.
Covision Media — Covision Media specializes in creating high-quality, relightable 3D models using their industrial 3D scanners. These scanners capture detailed surface information and PBR textures, and are designed for easy integration into virtual environments.

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Investment focus

Biotechnology, Health Care, Energy
Series A, Funding Round, Seed
Finland

Portfolio highlights

Desentum — Allergen immunotherapy that is effective, safe, patient-friendly and approved by the regulatory authorities.
Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.

Nostetta Ventures is a venture capital company investing in growth companies mainly in the North Savo region.

Investment focus

Health Care, Medical Device
Seed, Pre-Seed
Finland

Portfolio highlights

Marginum — Pioneering the next-generation quantitative surgical techniques.

XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.

Investment focus

Medical Device, Sensor, Medical
Series A, Series C, Funding Round
Finland, United States

Portfolio highlights

Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.

Metsola Ventures

Investment focus

Medical, mHealth, Health Care
Series A
Finland

Portfolio highlights

Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.

Nidoco AB is a Swedish investment company whose strategy is to create long-term value through active ownership of public and private companies.

Investment focus

Software, Health Care, Biotechnology
Seed, Funding Round, Series A
Finland, Sweden, Estonia

Portfolio highlights

Ponta — Connecting brands with real people paying attention.
Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
TactoTek — Set your imagination free and create user experiences with the help of sustainable smart molded structures.

The seed investor High-Tech Gründerfonds (HTGF) finances tech start-ups with growth potential and has supported more than 700 start-ups since 2005. With the launch of its fourth fund, HTGF now has about 1.4 billion euros under management. Its team of experienced investment managers and start-up experts support young companies with expertise,entrepreneurial spirit and passion. HTGF’s focus is on high-tech start-ups in the fields of digital tech, industrial tech, life sciences, chemistry and related business areas. To date, external investors have injected about 5 billion euros of capital into the HTGF portfolio via more than 2,000 follow-on financing rounds. In addition, HTGF has already successfully sold shares in more than 170 companies. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries. Fund investors in this public-private partnership include the German Federal Ministry for Economic Affairs and Climate Action, KfW Capital and 45 companies from a wide range of industries.

Investment focus

Software, Biotechnology, Information Technology
Seed, Series A, Funding Round
Germany, Switzerland, United States

Portfolio highlights

mo:re GmbH — Mo:re is building the new gold standard for organoid-based drug development by offering a lab platform that industrialises cell culture workflows.
Eyeo — eyeo revolutionizes imaging with color splitter sensors. Capture sharper, brighter images in low light using optical waveguide innovation, discover how it works
AICA SA — AICA believes programming robots should be at everyone's reach. We combine Artificial Intelligence & an intuitive interface, to help you relocate your production.

Noaber Ventures invests in initiatives that bring social transformations using information technology.

Investment focus

Health Care, Medical, Fitness
Seed, Series A, Funding Round
The Netherlands, Israel, Sweden

Portfolio highlights

Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Alba Health — Discover your baby's gut health & microbiome for the best start in life.

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Investment focus

Biotechnology, Health Care, Therapeutics
Series B, Series A, Series C
United States, Denmark, United Kingdom

Portfolio highlights

Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
Notify Therapeutics — Notify Therapeutics develops therapies for the treatment of infertility. By targeting the early and hormone-independent phase of egg maturation, the company aims at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. It utilizes drug-inducing factors that regulate the intracellular AKTpathway and target the early and hormone-independent phase of egg maturation for the treatment.
Women in Life Science Denmark — WiLD is a networking platform for women in senior positions in business and academia that is motivating and focused on science.

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Investment focus

Health Care, Biotechnology, Therapeutics
Funding Round, Series A, Series C
Finland, The Netherlands

Portfolio highlights

Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
SET Ventures — Venture capital firm focused on digital technologies for a carbon-free energy system

The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.

Investment focus

Apps, Hospital, Consulting
Seed, Grant, Pre-Seed
Finland, Luxembourg

Portfolio highlights

NADMED — The standard of NAD measuring
Solid IO — Solid IO is transforming precision oncology with organ-on-chip technology, delivering real-time, patient-specific insights to improve cancer treatment decisions.
Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol

Gerresheimer is a leading global partner to the pharma and healthcare industry. With our specialty glass and plastic products, we contribute to health and well-being. We have worldwide operations and about 10,000 employees manufacture our products in local markets, close to our customers. With our plants in Europe, North America, South America, andAsia, we generate revenues of approximately EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, refillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.

Investment focus

Health Care, Medical Device
Seed
Finland

Portfolio highlights

Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.

Restone Capital is an investment management organization focusing on smart energy, smart manufacturing and other fields.

Investment focus

Energy, Health Care, Manufacturing
Seed, Series A, Series B
China, Finland

Portfolio highlights

Marginum — Pioneering the next-generation quantitative surgical techniques.
Dehu Coating Film — Dehu Coating is an equipment manufacturing company that specializes in precise film forming technology R&D, manufacture, and sales.
Huamei new materials — Huamei new materials manufactures reaction sintered silicon carbide products, focusing on high-tech silicon carbide ceramics. Widely used in JG, aerospace, electronic semiconductors, liquid crystals, new energy vehicles, photovoltaic solar energy, metallurgy, chemical industry, machinery, papermaking, medicine, and almost every other industrialfield that requires high temperature resistance, thermal shock resistance, wear resistance, and corrosion resistance.

Inveni Capital is a venture capital management company focused on investments in early to growth stage life sciences companies.

Investment focus

Medical, Health Care, Biotechnology
Funding Round
Finland, United Kingdom

Portfolio highlights

BioSilta — BioSilta Ltd. is a privately-held company that utilizes its unique, proprietary EnBase® technology platform to develop innovative, reagent-based EnPresso® growth systems. When compared to conventional growth media, EnPresso growth systems significantly increase the yield of high quality biomolecules from microbial cultures.
Onbone — Onbone Ltd is a Finnish innovative company working on the field of medical technology. The company develops and markets innovative and user-friendly Woodcast products for orthopaedic and traumatology use. Onbone Ltd has eleven employees and the products are sold in Finland, Germany, Sweden, Holland and Great Britain.

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

Investment focus

Software, E-Commerce, Health Care
Seed, Angel, Series A
Italy, United States, United Kingdom

Portfolio highlights

ALKemist Bio — ALKemist Bio provides cell treatment to cancer patients.
Rubedo Life Sciences — Rubedo Life Sciences is the Premier Longevity Company. Rubedo discovers and develops medicines to keep you biologically young.
Restorative Neurotechnologies — Siamo un'azienda di dispositivi medicali certificati per la riabilitazione cognitiva ed il trattamento di disturbi cognitivi post ictus.

MVM invests in innovative healthcare companies. Our active portfolio companies are transforming the delivery of healthcare by enabling higher quality, cost-effective care in large, global markets.

Investment focus

Health Care, Biotechnology, Medical
Funding Round, Series B, Series C
United States, United Kingdom, Switzerland

Portfolio highlights

Ossio — OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.
Icotec — Icotec develops and produces carbon fiber reinforced plastic implants for spine surgeries and accident treatments.
Nalu Medical — Nalu Medical is an early-stage company that develops a range of medical devices. Their vision to modernize and improve the technology in medical devices, thus improving the lives of people.The Nalu neurostimulation system is a battery-free, micro-implantable pulse generator (iPG) currently cleared by the FDA for both Spinal Cord Stimulation (SCS)and Peripheral Nerve Stimulation (PNS) for mitigating chronic pain. The company was founded in 2014 and is based in Carlsbad, California.

Venture capital serves as funding for emerging, inventive enterprises poised for rapid expansion.

Investment focus

Software, SaaS, Machine Learning
Series A, Seed, Funding Round
United States, Israel, United Kingdom

Portfolio highlights

iDWELL — iDWELL (www.idwell.com) is a revolutionary CRM cloud software and tenant app, especially designed for the next generation of real estate management. It enables the automation of routine processes, and bundles as well as optimizes all communication between the stakeholders of a property, including service providers, asset managers, landlords,tenants and property managers. Currently, more than 750,000 apartment units are managed with the assistance of iDWELL.The iDWELL ticketing system and the connected tenant app automates routine maintenance tasks with regards to handling and reporting damages. This allows iDWELL customers to focus on more important and revenue-generating tasks. The iDWELL marketplace provides further opportunities to service tenants and landlords while generating revenue.
Crowded — Banking for Greek Life that allows you to seamlessly pay dues, P2P transfers, deposits, and make payments with your virtual debit card. Tailored tools for events, ticketing, chat organizational management and more.
INXY Payments — EU-licensed crypto platform enabling businesses to securely and legally accept, send, and exchange cryptocurrencies.Accept Crypto using Customizable Payment Gateway API:- Easily receive payments in multiple cryptocurrencies; - Auto-convert crypto to Euro or stablecoins; - Automated Bank settlement with full reporting; - Reach Millions of CryptoUsers for Increased Sales.Automate Crypto Payouts to Affiliates, Publishers, Suppliers & Employees:- Automate thousands of payments using file or API; - Automatically convert your assets to crypto for Mass Payouts; Tailored reports to suit accounting needs.Exchange crypto or fiat at low fees:- Direct transactions, avoiding large public exchange platforms; - Manual and automated exchange; - Easy & fee-free withdrawals  to any supported E-wallets or affordable transfers to bank account.Stay Compliant & Informed:- Real-time transactions monitoring (KYT) for safe dealings; - Comprehensive Transaction History & Detailed Reports; - Ensure EU Compliance with Our VASP crypto license; - Audit-Ready for Smooth Accounting. Tailored reports to suit accounting needs.INXY Payments: Simplifying crypto adoption for businesses. Save money, unlock crypto's potential, and seamlessly bridge Web2 to the future. Join us in making cryptocurrency as easy as fiat.

WE HELP YOU TO GROW FASTER!

Investment focus

Software, Information Technology, Internet
Seed, Funding Round, Series A
Finland, United States, United Kingdom

Portfolio highlights

Pebble — Pebble is a electric vehicle manufacturing startup.
Transfluent — Professional translations for all business needs. Fast. Easy.
BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Medical
Seed, Pre-Seed, Series A
United States, United Kingdom, Germany

Portfolio highlights

CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Sonar — Sonar is a scalable mental health platform for schools. We use a combination of AI and human connection to ensure every student is seen and supported. For educators, Sonar offers actionable insights to improve mental wellbeing, empower your staff, and boost student outcomes.
MedaSystems — Streamline patient and provider inquiries for Expanded Access or Compassionate Use with secure, 21st Century Cures Act compliant, cloud software.

Amor & Labor Oy is a venture capital that offers early stage investments for businesses.

Investment focus

Women's, Hardware, Software
Seed
Finland

Portfolio highlights

Augumenta — We develop intuitive and easy-to-use AR apps and tools that help companies improve their operational efficiency, quality, and safety.
Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.

Investors by industry

Artificial intelligence